PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE OF LANREOTIDE

To reduce both inconvenience and discomfort to the patients covered for more than 2 months or the patients not covered by the existing formulations.SOLUTION: The present invention relates to a pharmaceutical composition for a sustained release of lanreotide, in particular for a sustained release com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RUTH BIELSA GUIVERNAU, ANNE PETIT, JULIE FOURNES, ROLAND CHERIFIKH, DANIEL MARTINEZ LORENTE, JOEL RICHARD
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To reduce both inconvenience and discomfort to the patients covered for more than 2 months or the patients not covered by the existing formulations.SOLUTION: The present invention relates to a pharmaceutical composition for a sustained release of lanreotide, in particular for a sustained release compatible with therapeutic treatments for at least 2 months. The pharmaceutical compositions are particularly useful for the treatment of diseases lanreotide is indicated for.SELECTED DRAWING: None 【課題】２ヶ月を超えてカバーする又は既存の製剤ではカバーされない患者に対する不便さ及び不快感の両方を低減すること。【解決手段】本発明は、ランレオチドの持続放出用の医薬組成物、特に少なくとも２ヶ月の治療的処置に適する持続放出用の医薬組成物に関する。この医薬組成物は、ランレオチドが必要な疾患の治療に特に有用である。【選択図】なし